| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | transthyretin amyloidosis | TTR* | Ttr* | 4 models | Alliance of Genome Resources | ||
| | cerebral amyloid angiopathy | ITM2B | Itm2b* | 4 models | Alliance of Genome Resources | ||
| | amyloidosis | APCS* | Apcs | Alliance of Genome Resources | |||
| amyloidosis | GOT1* | Got1 | Alliance of Genome Resources | ||||
| amyloidosis | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
| amyloidosis | TTR* | Ttr | Alliance of Genome Resources | ||||
| APP-related cerebral amyloid angiopathy | APP* | App | Alliance of Genome Resources | ||||
| cerebral amyloid angiopathy | MME* | Mme | Alliance of Genome Resources | ||||
| cerebral amyloid angiopathy | OLR1* | Olr1 | Alliance of Genome Resources | ||||
| CST3-related cerebral amyloid angiopathy | CST3* | Cst3 | Alliance of Genome Resources | ||||
| familial visceral amyloidosis | APOA1* | Apoa1 | Alliance of Genome Resources | ||||
| familial visceral amyloidosis | B2M* | B2m | Alliance of Genome Resources | ||||
| familial visceral amyloidosis | FGA* | Fga | Alliance of Genome Resources | ||||
| familial visceral amyloidosis | LYZ* | Lyz1, Lyz2, Lyz3 | Alliance of Genome Resources | ||||
| Finnish type amyloidosis | GSN* | Gsn | Alliance of Genome Resources | ||||
| ITM2B-related cerebral amyloid angiopathy 1 | ITM2B* | Itm2b | Alliance of Genome Resources | ||||
| ITM2B-related cerebral amyloid angiopathy 2 | ITM2B* | Itm2b | Alliance of Genome Resources | ||||
| primary localized cutaneous amyloidosis 1 | OSMR* | Osmr | Alliance of Genome Resources | ||||
| primary localized cutaneous amyloidosis 2 | IL31RA* | Il31ra | Alliance of Genome Resources | ||||
| primary localized cutaneous amyloidosis 3 | GPNMB* | Gpnmb | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| amyloidosis | Tg(Mt1-IL6)28Gci | 1 model | |
| amyloidosis | Tg(CMV-IGL@AL080)55Dcs | 1 model | |
| amyloidosis | Tg(H2-L-IL6)46Kish | 1 model | |
| amyloidosis | Tg(Ly6a-GCSAM)102AIsg | 1 model | |
| cerebral amyloid angiopathy | Tg(Prnp-ITM2B*)1Ruvi | 3 models | |
| cerebral amyloid angiopathy | Tg(Prnp-APPSweArc)#Rmni | 1 model | |
| cerebral amyloid angiopathy | Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz | 2 models | |
| cerebral amyloid angiopathy | Tg(Thy1-APPSwDutIowa)BWevn | 1 model | |
| cerebral amyloid angiopathy | Tg(Thy1-APPDutch)#Jckr | 4 models | |
| cerebral amyloid angiopathy | Tg(APPswe,PSEN1dE9)85Dbo | 2 models | |
| cerebral amyloid angiopathy | Tg(Thy1-APP)3Somm | 1 model | |
| cerebral amyloid angiopathy | Tg(Prnp-ITM2B*)7Jckr | 1 model | |
| Finnish type amyloidosis | Tg(Ckm-GSN*D187N)AJewe | 2 models | |
| transthyretin amyloidosis | Tg(TTR-V30M)15Imeg | 3 models | |
| transthyretin amyloidosis | Tg(TTR)#Jbux | 1 model | |